Ligand profile
CHEMBL217754
Bioactivity hit from ChEMBL on a similar protein.
Bound to: KP13_01605 — Protease 2
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL217754- UniProt (similar protein)
P48147- pchembl
- 7.280 (~52.5 nM)
- Target protein
- KP13_01605
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 81.1
- −1 ≤ LogP ≤ 5 -1.53
- MW ≤ 500 Da 228.1
- LogP ≤ 5 -1.53
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 81.1
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC(=O)N(C)CC(=O)N1CCC[C@H]1B(O)OCC(=O)N(C)CC(=O)N1CCC[C@H]1B(O)O
InChI=1S/C9H17BN2O4/c1-7(13)11(2)6-9(14)12-5-3-4-8(12)10(15)16/h8,15-16H,3-6H2,1-2H3/t8-/m0/s1InChI=1S/C9H17BN2O4/c1-7(13)11(2)6-9(14)12-5-3-4-8(12)10(15)16/h8,15-16H,3-6H2,1-2H3/t8-/m0/s1
RORVKNCKCFHQRE-QMMMGPOBSA-NRORVKNCKCFHQRE-QMMMGPOBSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Curation
- pdb_similarity_tanimoto
- Binding sites
- PF00326
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL217754 →
- UniProt UniProt P48147 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL217754”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_01605.
PDB 4
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 99
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).